This focused review on the topic of cardiac and cancer rehabilitation is divided into 4 sections:

• Cardiac rehabilitation (23 minutes)
• Special populations (20 minutes)
• Cancer rehabilitation (21 minutes)
• Specific cancers(12 minutes)

Learning Objectives
After completing this enduring material, the participant should be able to:

• Describe indications and contraindications of a cardiac rehabilitation program
• Identify the significant considerations and components needed to prescribe a customized cardiac rehabilitation program for specific populations
• Recognize and describe all of the elements to be addressed when developing a pain management program for cancer patients, including patient history, current treatments, medications, prognosis, lifestyle, etc.
• Interpret the side effects of various cancer treatments and how they will impact the pain management program and functional outcomes for the patient

Accreditation Statement

AAPM&R is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Designation

AAPM&R designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and their Disclosures
All faculty, planners and reviewers participating in continuing medical education programs must disclose to the learner any financial interests with any commercial supporter or other relationships with manufacturer(s) or providers of any product or service related to content of their presentation.

Principal Faculty:
R. Samuel Mayer, MD
Ownership, WeLearnOn, LLC; receipt of royalties, Demos Publishers.

Peer Review:
Rishi Backshi, MD
Disclosed no relevant financial relationships.

AAPM&R Medical Education Committee:
Steve R. Flanagan, MD, Chair
Royalties from Springer Publishing; research grant from Brain Injury of America

John C. Cianca, MD, Vice Chair
Independent contractor, Houston Marathon Committee; owner, Musculoskeletal Ultrasound Consultants, LLC; consultant, 2nd MD; royalties from Demos Medical Publishing

Karen P. Barr, MD
Disclosed no relevant financial relationships.

Anna-Christina Bevelaqua, MD
Disclosed no relevant financial relationships.

Rachel A. Brakke Holman, MD
Disclosed no relevant financial relationships.

Joseph E. Burris, MD
Serves on the Speakers Bureau for, and received clinical research grants from Allergan.

Kevin N. Hakimi, MD
Disclosed no relevant financial relationships.

Rita G. Hamilton, DO
Disclosed no relevant financial relationships.

Charles D. Kenyon, DO (PHiT Liaison)
Disclosed no relevant financial relationships.

R. Sam Mayer, MD
Royalties from Demos Medical Publishing.

Atul T. Patel, MD, MHSA
Speakers Bureau for Allergan, Ipsen, Merz; participates in clinical trials for Ipsen, Merz, and Revance; Guideline and AUC Committee for the AAOS, nonremunerative position of influence.

Sunil Sabharwal, MD
Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.

G. Sunny Sharma, MD (PHiT Liaison)
Disclosed no relevant financial relationships.

Rebecca DeVivo, MPH, MSW, CHCP
Staff Liaison
Disclosed no relevant financial relationships.

Brian S. Thompson, MBA, FACEHP
Staff Liaison
Disclosed no relevant financial relationships.

No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.